Epirubicin hydrochloride

Epirubicin hydrochloride


Epirubicin hydrochloride is a semisynthetic L-arabino derivative of doxorubicin that inhibits Topoisomerase, DNA/RNA synthesis, and Foxp3, reducing regulatory T cell activity. A stereoisomer of doxorubicin, it undergoes β-glucuronidation, mitigating dose-limiting side effects. It is cytotoxic to HeLa cells (ID50 = 9 μM) and has shown efficacy alone or in combination therapies across various cancers, including breast, ovarian, lymphoma, pancreatic, gastric, and colorectal cancers. Reagent grade, for research use only.

Molecular structure of the compound BP-43652
    • Unit
    • Price
    • Qty
    • 50 MG
    • $210.00
    • 100 MG
    • $320.00
    • 250 MG
    • $540.00
    • 500 MG
    • $780.00

Usually ships within 24 hours.


Would you like to inquire about custom quantity?
Inquire